Inflation Reduction Act Pharmacy Provisions – Implications and Other Changes
Introduction This is the final article in a three-part series[1],[2] discussing the impact of the Inflation Reduction Act (IRA; H.R. 5376)[3] provisions. First, we’ll cover the Medicare Prescription Payment Plan (aka ‘out-of-pocket [...]
Inflation Reduction Act Pharmacy Provisions – Part D Changes
Introduction This is the second[1] in a three-part series discussing the impact of the Inflation Reduction Act (IRA; H.R. 5376)[2]provisions. Here we’ll look deeper into the changes coming to Medicare Part D, [...]
Diagnosis Co-Occurrence
Patients with multiple chronic diseases constitute a small minority of the total population but the majority of healthcare costs. These patient’s healthcare needs cannot be understood simply as the sum of each disease [...]
Understanding Provider Financial Losses in Value-Based Contracts
The shift from fee-for-service (FFS) healthcare models to value-based care (VBC) has been a monumental transformation in the healthcare industry. However, as this transition unfolds, it has added significant complexity to the healthcare [...]
Drug Price Negotiation Program
Introduction This is a follow-up to a prior Inspire Blog article[1] we posted and the first of three we’ll be posting now that more information, detail, and realities have come to pass; [...]
Differentiating Virtual Education to Optimize Outcomes
Study Authors: Erik D. Axene, MD, FACEP, MA and David V. Axene, FSA, FCA, CERA, MAAA Abstract: Prehospital medicine/patient care is a newer profession still being defined and, in many ways, redefining its [...]
Any views or opinions presented in these articles are solely those of the author and do not necessarily represent those of the company. AHP accepts no liability for the content of these articles, or for the consequences of any actions taken on the basis of the information provided unless that information is subsequently confirmed in writing.